MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference

Core Insights - MaxCyte, Inc. will release its financial results for Q4 and full year 2024 on March 11, 2025, after U.S. market close [1] - A conference call to discuss these results will be held at 4:30 p.m. Eastern Time on the same day [1] Earnings Conference Call Details - Investors must register online to listen to the conference call, with a recommendation to register at least a day in advance [2] - A live and archived webcast of the conference call will be available on MaxCyte's investor relations website [2] - Company management will also participate in the 45th Annual TD Cowen Healthcare Conference on March 3, 2025, at 10:30 a.m. ET [2] About MaxCyte - MaxCyte focuses on cell engineering to enhance patient outcomes, with over 25 years of expertise in developing advanced platforms [3] - The ExPERT™ platform, utilizing Flow Electroporation® technology, supports the growing cell therapy market from discovery to commercialization [3] - The ExPERT product family includes four instruments and a range of proprietary processing assemblies and software protocols, backed by a strong intellectual property portfolio [3]